ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.
GOLDEN, Colo., July 21, 2021 /PRNewswire/ -- ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device "ArcScan Insight® 100, " headquartered inGolden, Colorado, announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. ("Hao...
2021-07-21 20:33
8250